Overview upon miR-21 in lung cancer: focus on NSCLC
C Bica-Pop, R Cojocneanu-Petric, L Magdo… - Cellular and Molecular …, 2018 - Springer
Considering the high mortality rate encountered in lung cancer, there is a strong need to
explore new biomarkers for early diagnosis and also improved therapeutic targets to …
explore new biomarkers for early diagnosis and also improved therapeutic targets to …
[HTML][HTML] An emerging class of long non-coding RNA with oncogenic role arises from the snoRNA host genes
The small nucleolar RNA host genes (SNHGs) are a group of long non-coding RNAs, which
are reported in many studies as being overexpressed in various cancers. With very few …
are reported in many studies as being overexpressed in various cancers. With very few …
Non-coding RNA in bladder cancer
Bladder cancer is the tenth most common cancer worldwide and has been associated with
high mortality and morbidity. Although the treatment of bladder cancer is based on well …
high mortality and morbidity. Although the treatment of bladder cancer is based on well …
[HTML][HTML] Liquid biopsy biomarkers in urine: a route towards molecular diagnosis and personalized medicine of bladder cancer
M Ferro, E La Civita, A Liotti, M Cennamo… - Journal of personalized …, 2021 - mdpi.com
Bladder cancer (BC) is characterized by high incidence and recurrence rates together with
genomic instability and elevated mutation degree. Currently, cystoscopy combined with …
genomic instability and elevated mutation degree. Currently, cystoscopy combined with …
[HTML][HTML] CircRNA-Cdr1as exerts anti-oncogenic functions in bladder cancer by sponging MicroRNA-135a
P Li, X Yang, W Yuan, C Yang, X Zhang… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: CircRNAs regulate gene expression in different malignancies. However,
the role of Cdr1as in the tumourigenesis of bladder cancer and its potential mechanisms …
the role of Cdr1as in the tumourigenesis of bladder cancer and its potential mechanisms …
[HTML][HTML] Bladder cancer: new insights into its molecular pathology
K Inamura - Cancers, 2018 - mdpi.com
Bladder cancer is one of the most prevalent cancers worldwide. Unfortunately, there have
been few advances in its clinical management due to a poor understanding of the …
been few advances in its clinical management due to a poor understanding of the …
[HTML][HTML] Current insights into oral cancer epigenetics
AI Irimie, C Ciocan, D Gulei, N Mehterov… - International journal of …, 2018 - mdpi.com
Epigenetic modifications have emerged into one of the cancer hallmarks, replacing the
concept of malignant pathologies as being solely genetic-based conditions. The epigenetic …
concept of malignant pathologies as being solely genetic-based conditions. The epigenetic …
Natural compounds modulate the crosstalk between apoptosis-and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells
C Braicu, O Zanoaga, AA Zimta, AB Tigu… - Seminars in Cancer …, 2022 - Elsevier
Due to the high number of annual cancer–related deaths, and the economic burden that this
malignancy affects today's society, the study of compounds isolated from natural sources …
malignancy affects today's society, the study of compounds isolated from natural sources …
[HTML][HTML] Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer
L Gan, L Lv, S Liao - International journal of oncology, 2019 - spandidos-publications.com
Gastric cancer (GC) is the fifth most prevalent type of malignancy and the third leading cause
of cancer‑related mortality worldwide, with the prognosis of patients with late‑stage GC …
of cancer‑related mortality worldwide, with the prognosis of patients with late‑stage GC …
Identification of a nomogram from ferroptosis‐related long noncoding RNAs signature to analyze overall survival in patients with bladder cancer
Y Cui, Z Zhou, Y Chai, X Che, Y Zhang - Journal of oncology, 2021 - Wiley Online Library
Purpose. This study aimed to establish a nomogram to predict the overall survival (OS) of
patients with bladder cancer (BC) by ferroptosis‐related long noncoding RNAs (FRlncRNAs) …
patients with bladder cancer (BC) by ferroptosis‐related long noncoding RNAs (FRlncRNAs) …